Although the promotion role of CAFs in cancer stemness has been supported by increasing studies, and multiple CAFs targeting strategies have been proposed for precise anti-CSCs treatment, the definite effect of CAFs on CSCs in different cancer types is controversial, and the underlying mechanism is still remaining to exposure [6, 7]. The gene discussed is TBX1; the disease is cancer.